Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Aderamastat by Foresee Pharmaceuticals for Sarcoidosis: Likelihood of Approval
Aderamastat is under clinical development by Foresee Pharmaceuticals and currently in Phase I for Sarcoidosis. According to GlobalData, Phase I...